Competition is coming for a top drug
Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out.
Learn more about your ad choices. Visit megaphone.fm/adchoices